568
Participants
Start Date
November 21, 2022
Primary Completion Date
May 15, 2025
Study Completion Date
July 7, 2031
Asciminib
Asciminib 80 mg QD administered under fasting conditions.
Nilotinib
Nilotinib 300 mg BID administered under fasting conditions.
Novartis Investigative Site, Khoudh
Novartis Investigative Site, Geneva
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Soweto
Novartis Investigative Site, Eger
Novartis Investigative Site, Plovdiv
Novartis Investigative Site, Pleven
Novartis Investigative Site, Varna
Novartis Investigative Site, Torino
Novartis Investigative Site, Uijeongbu-si
Novartis Investigative Site, Amman
Novartis Investigative Site, Marseille
Novartis Investigative Site, Berlin
Novartis Investigative Site, Bundang Gu
Novartis Investigative Site, Caen
Novartis Investigative Site, Bad Saarow
Novartis Investigative Site, Milan
Novartis Investigative Site, Hamburg
Virginia Oncology Associates, Norfolk
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Bremen
Messino Cancer Centers, Asheville
Novartis Investigative Site, Hanover
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Paderborn
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Marburg
Novartis Investigative Site, Izmir
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Velbert
Novartis Investigative Site, Nantes
Novartis Investigative Site, Essen
Oncology Hematology Care Inc, Cincinnati
Novartis Investigative Site, Petaling Jaya
Novartis Investigative Site, Meldola
Novartis Investigative Site, Aachen
Novartis Investigative Site, Bonn
Novartis Investigative Site, Vandœuvre-lès-Nancy
Regions Hospital, Saint Paul
Novartis Investigative Site, Pisa
Novartis Investigative Site, Lille
Novartis Investigative Site, Kuala Lumpur
Novartis Investigative Site, Frankfurt am Main
Illinois Cancer Care, Peoria
Novartis Investigative Site, Clermont-Ferrand
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Mannheim
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Lyon
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Paris
Texas Oncology P A, Bedford
Texas Oncology PA Bedford, Bedford
Novartis Investigative Site, Freiburg im Breisgau
Rocky Mountain Cancer Centers, Boulder
Novartis Investigative Site, München
Novartis Investigative Site, Munich
Novartis Investigative Site, Poitiers
Novartis Investigative Site, Augsburg
Novartis Investigative Site, Ulm
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Regensburg
Novartis Investigative Site, Kuching
Novartis Investigative Site, Bayreuth
Novartis Investigative Site, Würzburg
Williamette Cancer Center, Eugene
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Singapore
Novartis Investigative Site, Singapore
Novartis Investigative Site, Craiova
Novartis Investigative Site, Varanasi
Novartis Investigative Site, Rishikesh
Novartis Investigative Site, Timișoara
Novartis Investigative Site, Ahmedabad
Novartis Investigative Site, Cluj-Napoca
Novartis Investigative Site, Târgu Mureş
Novartis Investigative Site, Sibiu
Novartis Investigative Site, Chennai
Novartis Investigative Site, CABA
Novartis Investigative Site, CABA
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, London
Novartis Investigative Site, Toronto
Novartis Investigative Site, Brno
Novartis Investigative Site, Plzen Bory
Novartis Investigative Site, Prague
Novartis Investigative Site, Prague
Novartis Investigative Site, Nice
Novartis Investigative Site, Dresden
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Halle
Novartis Investigative Site, Jena
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Athens
Novartis Investigative Site, Athens
Novartis Investigative Site, Ioannina
Novartis Investigative Site, Pátrai
Novartis Investigative Site, Thessaloniki
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Roma
Novartis Investigative Site, Alor Star
Novartis Investigative Site, Dordrecht
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Singapore
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Pretoria
Novartis Investigative Site, Ankara
Novartis Investigative Site, Abu Dhabi
Novartis Investigative Site, Glasgow
Novartis Investigative Site, Gloucester
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Newport
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY